Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

CT-guided transthoracic needle biopsy: advantages in histopathological and molecular tests.

Porrello C, Gullo R, Gagliardo CM, Vaglica A, Palazzolo M, Giangregorio F, Iadicola D, Catanzaro A, Scerrino G, Lo Faso F, Carini F, Tomasello G.

Future Oncol. 2019 Oct 9. doi: 10.2217/fon-2019-0076. [Epub ahead of print]

PMID:
31596139
2.

Novel Antimycobacterial Compounds Suppress NAD Biogenesis by Targeting a Unique Pocket of NaMN Adenylyltransferase.

Osterman AL, Rodionova I, Li X, Sergienko E, Ma CT, Catanzaro A, Pettigrove ME, Reed RW, Gupta R, Rohde KH, Korotkov KV, Sorci L.

ACS Chem Biol. 2019 May 17;14(5):949-958. doi: 10.1021/acschembio.9b00124. Epub 2019 Apr 17.

PMID:
30969758
3.

Valley coherent exciton-polaritons in a monolayer semiconductor.

Dufferwiel S, Lyons TP, Solnyshkov DD, Trichet AAP, Catanzaro A, Withers F, Malpuech G, Smith JM, Novoselov KS, Skolnick MS, Krizhanovskii DN, Tartakovskii AI.

Nat Commun. 2018 Nov 15;9(1):4797. doi: 10.1038/s41467-018-07249-z.

4.

My Dog Is Not My Cat: Owner Perception of the Personalities of Dogs and Cats Living in the Same Household.

Menchetti L, Calipari S, Guelfi G, Catanzaro A, Diverio S.

Animals (Basel). 2018 May 24;8(6). pii: E80. doi: 10.3390/ani8060080.

5.

Validation of the Italian version of the UNESP-Botucatu multidimensional composite pain scale for the assessment of postoperative pain in cats.

Della Rocca G, Catanzaro A, Conti MB, Bufalari A, De Monte V, Di Salvo A, Tabarelli Brondani J, Pacca Loureiro Luna S.

Vet Ital. 2018 Mar 31;54(1):49-61. doi: 10.12834/VetIt.567.2704.2.

6.

Cost analysis of rapid diagnostics for drug-resistant tuberculosis.

Groessl EJ, Ganiats TG, Hillery N, Trollip A, Jackson RL, Catanzaro DG, Rodwell TC, Garfein RS, Rodrigues C, Crudu V, Victor TC, Catanzaro A.

BMC Infect Dis. 2018 Mar 2;18(1):102. doi: 10.1186/s12879-018-3013-0.

7.

Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.

Al Natour RH, Catanzaro A, Zolotarevsky E, DeBenedet AT, Gunaratnam NT.

Dis Esophagus. 2018 Jan 1;31(1):1-6. doi: 10.1093/dote/dox126.

PMID:
29087500
8.

Imaging of Interlayer Coupling in van der Waals Heterostructures Using a Bright-Field Optical Microscope.

Alexeev EM, Catanzaro A, Skrypka OV, Nayak PK, Ahn S, Pak S, Lee J, Sohn JI, Novoselov KS, Shin HS, Tartakovskii AI.

Nano Lett. 2017 Sep 13;17(9):5342-5349. doi: 10.1021/acs.nanolett.7b01763. Epub 2017 Aug 3.

9.

A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis.

Ramirez-Busby SM, Rodwell TC, Fink L, Catanzaro D, Jackson RL, Pettigrove M, Catanzaro A, Valafar F.

Sci Rep. 2017 Jun 19;7(1):3790. doi: 10.1038/s41598-017-03452-y.

10.

Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.

Thompson GR 3rd, Blair JE, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Lopez R, Heidari A, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B, Johnson R.

Clin Infect Dis. 2017 Jul 15;65(2):338-341. doi: 10.1093/cid/cix318.

11.

Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis.

Catanzaro DG, Trollip AP, Seifert M, Georghiou SB, Garfein RS, Rodwell TC, Catanzaro A, Eisenach KD.

Eur Respir J. 2017 Apr 5;49(4). pii: 1602215. doi: 10.1183/13993003.02215-2016. Print 2017 Apr. No abstract available.

12.

Corrigendum to "Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables" [Int. J. Mycobacteriol. 5(1) 2016 1-6].

Kambli P, Ajbani K, Nikam C, Sadani M, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C.

Int J Mycobacteriol. 2016 Sep;5(3):370-372. doi: 10.1016/j.ijmyco.2016.06.009. Epub 2016 Jun 27. No abstract available.

13.

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.

Georghiou SB, Seifert M, Lin SY, Catanzaro D, Garfein RS, Jackson RL, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC.

BMC Infect Dis. 2016 Aug 31;16:458. doi: 10.1186/s12879-016-1781-y.

14.

Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.

Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N.

Clin Infect Dis. 2016 Sep 15;63(6):717-22. doi: 10.1093/cid/ciw538.

PMID:
27559032
15.

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.

Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, Johnson RH, Kusne S, Lisse J, MacDonald JD, Meyerson SL, Raksin PB, Siever J, Stevens DA, Sunenshine R, Theodore N.

Clin Infect Dis. 2016 Sep 15;63(6):e112-46. doi: 10.1093/cid/ciw360. Epub 2016 Jul 27.

PMID:
27470238
16.

Annual risk of tuberculosis infection in rural China: a population-based prospective study.

Gao L, Bai L, Liu J, Lu W, Wang X, Li X, Du J, Chen X, Zhang H, Xin H, Sui H, Li H, Su H, He J, Pan S, Peng H, Xu Z, Catanzaro A, Evans TG, Zhang Z, Ma Y, Li M, Feng B, Li Z, Guan L, Shen F, Wang Z, Zhu T, Yang S, Si H, Wang Y, Tan Y, Chen T, Chen C, Xia Y, Cheng S, Xu W, Jin Q; LATENTTB-NSTM study team.

Eur Respir J. 2016 Jul;48(1):168-78. doi: 10.1183/13993003.00235-2016. Epub 2016 May 26.

17.

Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.

Georghiou SB, Seifert M, Catanzaro D, Garfein RS, Valafar F, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):3994-4004. doi: 10.1128/AAC.00222-16. Print 2016 Jul.

18.

A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis.

Seifert M, Ajbani K, Georghiou SB, Catanzaro D, Rodrigues C, Crudu V, Victor TC, Garfein RS, Catanzaro A, Rodwell TC.

Int J Tuberc Lung Dis. 2016 May;20(5):631-7. doi: 10.5588/ijtld.15.0788.

19.

Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.

Berrada ZL, Lin SY, Rodwell TC, Nguyen D, Schecter GF, Pham L, Janda JM, Elmaraachli W, Catanzaro A, Desmond E.

Diagn Microbiol Infect Dis. 2016 Jun;85(2):177-81. doi: 10.1016/j.diagmicrobio.2016.01.019. Epub 2016 Feb 3.

20.

Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.

Kambli P, Ajbani K, Nikam C, Sadani M, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C.

Int J Mycobacteriol. 2016 Mar;5(1):1-6. doi: 10.1016/j.ijmyco.2015.09.001. Epub 2015 Oct 1. Erratum in: Int J Mycobacteriol. 2016 Sep;5(3):370-372.

21.

Redefining MTBDRplus test results: what do indeterminate results actually mean?

Nikam C, Patel R, Sadani M, Ajbani K, Kazi M, Soman R, Shetty A, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C.

Int J Tuberc Lung Dis. 2016 Feb;20(2):154-9. doi: 10.5588/ijtld.15.0319.

22.

Pharmacokinetic profiles of meloxicam in turtles (Trachemys scripta scripta) after single oral, intracoelomic and intramuscular administrations.

Di Salvo A, Giorgi M, Catanzaro A, Deli G, della Rocca G.

J Vet Pharmacol Ther. 2016 Feb;39(1):102-5. doi: 10.1111/jvp.12254. Epub 2015 Aug 12.

PMID:
26789011
23.

MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis.

Seifert M, Georghiou SB, Catanzaro D, Rodrigues C, Crudu V, Victor TC, Garfein RS, Catanzaro A, Rodwell TC.

J Clin Microbiol. 2016 Apr;54(4):912-8. doi: 10.1128/JCM.02505-15. Epub 2016 Jan 13.

24.

Preliminary study on attitudes, opinions and knowledge of Italian veterinarians with regard to abdominal visceral pain in dogs.

Catanzaro A, Di Salvo A, Steagall PV, Zampini D, Polisca A, Della Rocca G.

Vet Anaesth Analg. 2016 Jul;43(4):361-70. doi: 10.1111/vaa.12326. Epub 2015 Dec 14.

PMID:
26662657
25.

Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.

Kambli P, Ajbani K, Nikam C, Khillari A, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1227-9. doi: 10.5588/ijtld.14.0277.

26.

Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.

ElMaraachli W, Slater M, Berrada ZL, Lin SY, Catanzaro A, Desmond E, Rodrigues C, Victor TC, Crudu V, Gler MT, Rodwell TC.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1222-6. doi: 10.5588/ijtld.14.0936.

27.

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis.

Catanzaro A, Rodwell TC, Catanzaro DG, Garfein RS, Jackson RL, Seifert M, Georghiou SB, Trollip A, Groessl E, Hillery N, Crudu V, Victor TC, Rodrigues C, Lin GS, Valafar F, Desmond E, Eisenach K.

PLoS One. 2015 Aug 31;10(8):e0136861. doi: 10.1371/journal.pone.0136861. eCollection 2015.

28.

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.

Torres JN, Paul LV, Rodwell TC, Victor TC, Amallraja AM, Elghraoui A, Goodmanson AP, Ramirez-Busby SM, Chawla A, Zadorozhny V, Streicher EM, Sirgel FA, Catanzaro D, Rodrigues C, Gler MT, Crudu V, Catanzaro A, Valafar F.

Emerg Microbes Infect. 2015 Jul;4(7):e42. doi: 10.1038/emi.2015.42. Epub 2015 Jul 15.

29.

Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing.

Colman RE, Schupp JM, Hicks ND, Smith DE, Buchhagen JL, Valafar F, Crudu V, Romancenco E, Noroc E, Jackson L, Catanzaro DG, Rodwell TC, Catanzaro A, Keim P, Engelthaler DM.

PLoS One. 2015 May 13;10(5):e0126626. doi: 10.1371/journal.pone.0126626. eCollection 2015.

30.

Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.

Garfein RS, Catanzaro DG, Rodwell TC, Avalos E, Jackson RL, Kaping J, Evasco H, Rodrigues C, Crudu V, Lin SY, Groessl E, Hillery N, Trollip A, Ganiats T, Victor TC, Eisenach K, Valafar F, Channick J, Qian L, Catanzaro A.

Int J Tuberc Lung Dis. 2015 Apr;19(4):420-7. doi: 10.5588/ijtld.14.0488. Erratum in: Int J Tuberc Lung Dis. 2015 Jul;19(7):874. Groessel, E [corrected to Groessl, E].

31.

Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.

Avalos E, Catanzaro D, Catanzaro A, Ganiats T, Brodine S, Alcaraz J, Rodwell T.

PLoS One. 2015 Mar 27;10(3):e0120470. doi: 10.1371/journal.pone.0120470. eCollection 2015. Review.

32.

Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.

Seifert M, Catanzaro D, Catanzaro A, Rodwell TC.

PLoS One. 2015 Mar 23;10(3):e0119628. doi: 10.1371/journal.pone.0119628. eCollection 2015. Review.

33.

Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations.

Kambli P, Ajbani K, Sadani M, Nikam C, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C.

Diagn Microbiol Infect Dis. 2015 May;82(1):49-53. doi: 10.1016/j.diagmicrobio.2015.01.009. Epub 2015 Jan 29.

34.

Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study.

Gao L, Lu W, Bai L, Wang X, Xu J, Catanzaro A, Cárdenas V, Li X, Yang Y, Du J, Sui H, Xia Y, Li M, Feng B, Li Z, Xin H, Zhao R, Liu J, Pan S, Shen F, He J, Yang S, Si H, Wang Y, Xu Z, Tan Y, Chen T, Xu W, Peng H, Wang Z, Zhu T, Zhou F, Liu H, Zhao Y, Cheng S, Jin Q; LATENTTB-NSTM study team.

Lancet Infect Dis. 2015 Mar;15(3):310-9. doi: 10.1016/S1473-3099(14)71085-0. Epub 2015 Feb 11.

PMID:
25681063
35.

Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.

Kambli P, Ajbani K, Sadani M, Nikam C, Shetty A, Udwadia Z, Rodwell TC, Catanzaro A, Rodrigues C.

Tuberculosis (Edinb). 2015 Mar;95(2):137-41. doi: 10.1016/j.tube.2014.11.003. Epub 2014 Dec 3.

36.

Intra-articular administration of lidocaine in anaesthetized dogs: pharmacokinetic profile and safety on cardiovascular and nervous systems.

Di Salvo A, Bufalari A, De Monte V, Cagnardi P, Marenzoni ML, Catanzaro A, Vigorito V, Della Rocca G.

J Vet Pharmacol Ther. 2015 Aug;38(4):350-6. doi: 10.1111/jvp.12187. Epub 2014 Nov 27.

PMID:
25428796
37.

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis.

Hillery N, Groessl EJ, Trollip A, Catanzaro D, Jackson L, Rodwell TC, Garfein RS, Lin SY, Eisenach K, Ganiats TG, Park D, Valafar F, Rodrigues C, Crudu V, Victor TC, Catanzaro A.

Trials. 2014 Nov 6;15:434. doi: 10.1186/1745-6215-15-434.

38.

Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.

Ajbani K, Lin SY, Rodrigues C, Nguyen D, Arroyo F, Kaping J, Jackson L, Garfein RS, Catanzaro D, Eisenach K, Victor TC, Crudu V, Gler MT, Ismail N, Desmond E, Catanzaro A, Rodwell TC.

Antimicrob Agents Chemother. 2015 Jan;59(1):414-20. doi: 10.1128/AAC.03614-14. Epub 2014 Nov 3.

39.

Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens.

Lin SY, Rodwell TC, Victor TC, Rider EC, Pham L, Catanzaro A, Desmond EP.

J Clin Microbiol. 2014 Feb;52(2):475-82. doi: 10.1128/JCM.01821-13. Epub 2013 Nov 27.

40.

Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.

Trollip AP, Moore D, Coronel J, Caviedes L, Klages S, Victor T, Romancenco E, Crudu V, Ajbani K, Vineet VP, Rodrigues C, Jackson RL, Eisenach K, Garfein RS, Rodwell TC, Desmond E, Groessl EJ, Ganiats TG, Catanzaro A.

Int J Tuberc Lung Dis. 2014 Feb;18(2):227-32. doi: 10.5588/ijtld.13.0229.

41.

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.

Rodwell TC, Valafar F, Douglas J, Qian L, Garfein RS, Chawla A, Torres J, Zadorozhny V, Kim MS, Hoshide M, Catanzaro D, Jackson L, Lin G, Desmond E, Rodrigues C, Eisenach K, Victor TC, Ismail N, Crudu V, Gler MT, Catanzaro A.

J Clin Microbiol. 2014 Mar;52(3):781-9. doi: 10.1128/JCM.02701-13. Epub 2013 Dec 18.

42.

Routine CSF analysis in coccidioidomycosis is not required.

Thompson G 3rd, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Taylor S, Lopez R, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B.

PLoS One. 2013 May 22;8(5):e64249. doi: 10.1371/journal.pone.0064249. Print 2013. Review.

43.

Multidrug-resistant tuberculosis among patients in Baja California, Mexico, and Hispanic patients in California.

Bojorquez I, Barnes RF, Flood J, López-Gatell H, Garfein RS, Bäcker CE, Alpuche C, Vinetz JM, Catanzaro A, Kato-Maeda M, Rodwell TC.

Am J Public Health. 2013 Jul;103(7):1301-5. doi: 10.2105/AJPH.2012.301039. Epub 2013 May 16.

44.

A summary of meeting proceedings on addressing variability around the cut point in serial interferon-γ release assay testing.

Daley CL, Reves RR, Beard MA, Boyle J, Clark RB, Beebe JL, Catanzaro A, Chen L, Desmond E, Dorman SE, Hudson TW, Lardizabal AA, Kapoor H, Marder DC, Miranda C, Narita M, Reichman L, Schwab D, Seaworth BJ, Terpeluk P, Thanassi W, Kawamura LM.

Infect Control Hosp Epidemiol. 2013 Jun;34(6):625-30. doi: 10.1086/670635. Epub 2013 Apr 19.

PMID:
23651895
45.

A summary of the Third Global Interferon-γ Release Assay Symposium.

Catanzaro A, Daley C.

Infect Control Hosp Epidemiol. 2013 Jun;34(6):619-24. doi: 10.1086/670634. Epub 2013 Apr 22.

PMID:
23651894
46.

Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis.

Bentley TG, Catanzaro A, Ganiats TG.

BMC Res Notes. 2012 Oct 10;5:563. doi: 10.1186/1756-0500-5-563.

47.

Multiple gastric metastases from ovarian carcinoma diagnosed by endoscopic ultrasound with fine needle aspiration.

Akce M, Bihlmeyer S, Catanzaro A.

Case Rep Gastrointest Med. 2012;2012:610527. doi: 10.1155/2012/610527. Epub 2012 Jul 1.

48.

Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients.

Kunnath-Velayudhan S, Davidow AL, Wang HY, Molina DM, Huynh VT, Salamon H, Pine R, Michel G, Perkins MD, Xiaowu L, Felgner PL, Flynn JL, Catanzaro A, Gennaro ML.

J Infect Dis. 2012 Sep 1;206(5):697-705. doi: 10.1093/infdis/jis421. Epub 2012 Jun 25.

49.

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.

Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC.

PLoS One. 2012;7(3):e33275. doi: 10.1371/journal.pone.0033275. Epub 2012 Mar 29. Review.

50.

Coccidioidomycosis during pregnancy: a review and recommendations for management.

Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM.

Clin Infect Dis. 2011 Aug;53(4):363-8. doi: 10.1093/cid/cir410. Review.

PMID:
21810749

Supplemental Content

Loading ...
Support Center